TGFβ Signaling and Cardiovascular Diseases

被引：2

作者：

Pardali, Evangelia ^{[1
]}

ten Dijke, Peter ^{[2
,3
]}

机构：

[1] Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany

[2] Leiden Univ, Med Ctr, Ctr Biomed Genet, Leiden, Netherlands

[3] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2012年 / 8卷 / 02期

关键词：

atherosclerosis; BMP; hypertension; Smad; TGF beta; vessel calcification; TRANSFORMING-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; BONE MORPHOGENETIC PROTEIN; HEREDITARY HEMORRHAGIC TELANGIECTASIA; PULMONARY ARTERIAL-HYPERTENSION; NITRIC-OXIDE SYNTHASE; HUMAN ATHEROSCLEROTIC LESIONS; VASCULAR ENDOTHELIAL-CELLS; AORTIC-ANEURYSM PROGRESSION; RECEPTOR-LIKE KINASE-1;

D O I：

10.7150/ijbs.8.195

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Transforming growth factor beta (TGF beta) family members are involved in a wide range of diverse functions and play key roles in embryogenesis, development and tissue homeostasis. Perturbation of TGF beta signaling may lead to vascular and other diseases. In vitro studies have provided evidence that TGF beta family members have a wide range of diverse effects on vascular cells, which are highly dependent on cellular context. Consistent with these observations genetic studies in mice and humans showed that TGF beta family members have ambiguous effects on the function of the cardiovascular system. In this review we discuss the recent advances on TGF beta signaling in (cardio) vascular diseases, and describe the value of TGF beta signaling as both a disease marker and therapeutic target for (cardio) vascular diseases.

引用

页码：195 / 213

页数：19

共 50 条

[21] Positive and negative regulation of TGF-β signaling
Miyazono, K
JOURNAL OF CELL SCIENCE, 2000, 113 (07) : 1101 - 1109
[22] Cell signaling and biological pathway in cardiovascular diseases
Cheong-Whan Chae
Yoo-Wook Kwon
Archives of Pharmacal Research, 2019, 42 : 195 - 205
[23] Wnt/β-catenin Signaling Cascades in Cardiovascular Diseases
Qi, Yan-Fei
Liu, Yan-Ping
Xu, Wen-Qing
Yan, Xiao-Xue
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2024, 51 (10) : 2328 - 2339
[24] Cell signaling and biological pathway in cardiovascular diseases
Chae, Cheong-Whan
Kwon, Yoo-Wook
ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (03) : 195 - 205
[25] Roles and potential clinical implications of tissue transglutaminase in cardiovascular diseases
Chen, Shiqi
Ma, Jingwei
Chi, Jiangyang
Zhang, Bingxia
Zheng, Xiaojuan
Chen, Jie
Liu, Junwei
PHARMACOLOGICAL RESEARCH, 2022, 177
[26] Epigenetic Biomarkers in Cardiovascular Diseases
Soler-Botija, Carolina
Galvez-Monton, Carolina
Bayes-Genis, Antoni
FRONTIERS IN GENETICS, 2019, 10
[27] TGF-β Signaling
Tzavlaki, Kalliopi
Moustakas, Aristidis
BIOMOLECULES, 2020, 10 (03)
[28] DNA damage response signaling: A common link between cancer and cardiovascular diseases
Nikfarjam, Sepideh
Singh, Krishna K.
CANCER MEDICINE, 2023, 12 (04): : 4380 - 4404
[29] Toll-like Receptor Signaling Pathways in Cardiovascular Diseases: Challenges and Opportunities
Bijani, Faezeh Moghimpour
Vallejo, Jesus G.
Rezaei, Nima
INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2012, 31 (05) : 379 - 395
[30] microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases
de Lucia, Claudio
Komici, Klara
Borghetti, Giulia
Femminella, Grazia Daniela
Bencivenga, Leonardo
Cannavo, Alessandro
Corbi, Graziamaria
Ferrara, Nicola
Houser, Steven R.
Koch, Walter J.
Rengo, Giuseppe
FRONTIERS IN MEDICINE, 2017, 4

← 1 2 3 4 5 →